We are live on ! Find out more
MNTA

Momenta Pharmaceuticals, Inc.
MNTA

Delisted

MNTA was delisted on the 30th of September, 2020.

Back to rankings

0 hedge funds and large institutions have $0 invested in Momenta Pharmaceuticals, Inc. in 2020 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 211 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 211 → 0 (-211)

100% less funds holding in top 10

Funds holding in top 10: 16 → 0 (-16)

100% less capital invested

Capital invested by funds: $5.44B → $0 (-$5.44B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 211

Holders
–
Holders Change
-211
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-16
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
211
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$1.01B
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$685M
3
Vanguard Group
Vanguard Group
Pennsylvania
-$622M
4
HI
HBK Investments
Texas
-$257M
5
State Street
State Street
Massachusetts
-$238M
Name Holding Trade Value Shares
Change 		Change in
Stake
FTCM
51
First Trust Capital Management
Illinois
– -$16.3M -309,814 Closed
Public Sector Pension Investment Board (PSP Investments)
52
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
– -$15.9M -303,128 Closed
Primecap Management
53
Primecap Management
California
– -$15.5M -295,070 Closed
Two Sigma Advisers
54
Two Sigma Advisers
New York
– -$14.3M -272,300 Closed
Handelsbanken Fonder
55
Handelsbanken Fonder
Sweden
– -$14M -266,260 Closed
TAL
56
TIG Advisors LLC
New York
– -$14M -266,080 Closed
KC
57
Kellner Capital
New York
– -$13.7M -260,300 Closed
Susquehanna International Group
58
Susquehanna International Group
Pennsylvania
– -$13.4M -255,154 Closed
Swiss National Bank
59
Swiss National Bank
Switzerland
– -$13.3M -253,400 Closed
CC
60
Carlson Capital
Texas
– -$13.2M -250,776 Closed
Barclays
61
Barclays
United Kingdom
– -$13.1M -248,815 Closed
California Public Employees Retirement System
62
California Public Employees Retirement System
California
– -$13M -247,019 Closed
BHMP
63
Bardin Hill Management Partners
New York
– -$12.6M -239,739 Closed
CS
64
Candriam SCA
Luxembourg
– -$11.5M -219,575 Closed
PPA
65
Parametric Portfolio Associates
Washington
– -$11.3M -216,130 Closed
State of Wisconsin Investment Board
66
State of Wisconsin Investment Board
Wisconsin
– -$11.3M -215,366 Closed
PCM
67
Prelude Capital Management
New York
– -$11.1M -212,323 Closed
California State Teachers Retirement System (CalSTRS)
68
California State Teachers Retirement System (CalSTRS)
California
– -$9.89M -188,380 Closed
New York State Teachers Retirement System (NYSTRS)
69
New York State Teachers Retirement System (NYSTRS)
New York
– -$9.14M -174,144 Closed
TRCT
70
Tower Research Capital (TRC)
New York
– -$8.24M -157,033 Closed
C
71
Chescapmanager
Maryland
– -$7.88M -150,000 Closed
Walleye Trading
72
Walleye Trading
New York
– -$7.87M -150,000 Closed
AC
73
Athos Capital
Hong Kong
– -$7.74M -147,500 Closed
Macquarie Group
74
Macquarie Group
Australia
– -$7.68M -146,347 Closed
Deutsche Bank
75
Deutsche Bank
Germany
– -$7.55M -143,825 Closed
1 2
3
4 5

MNTA Hedge Fund Activity: Q4 2020 in Review

0 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Momenta Pharmaceuticals, Inc. (MNTA) for Q4 2020, worth a combined $0 — down 100% from $5.44B a quarter earlier.

Sellers outnumbered buyers: 211 funds closed out of MNTA and 0 opened new positions — a net loss of 211 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was BlackRock, exiting entirely with an estimated $1.01B sold.

  • 0 institutional investors held Momenta Pharmaceuticals, Inc. (MNTA) as of Q4 2020, down from 211 in Q3 2020.
  • Funds reported $0 of Momenta Pharmaceuticals, Inc. stock for Q4 2020, down 100% quarter-over-quarter.
  • 0 funds opened new Momenta Pharmaceuticals, Inc. positions in Q4 2020 and 211 closed out, a net change of -211 holders.
  • The largest Momenta Pharmaceuticals, Inc. seller in Q4 2020 was BlackRock, an estimated $1.01B sold.

Based on aggregated 13F filings for Q4 2020.